Burns Woodward, MD
Private practice of psychiatry, Norwood and Newton, Massachusetts
Dr. Woodward has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
We’ve all been taught not to prescribe addictive drugs to patients who will abuse them, but in the real world it is not always easy to tell who those patients are or to manage the resulting problems.
Jessica L. Gören, PharmD, BCPP
Associate professor, University of Rhode Island
Instructor in Psychiatry, Harvard University
Clinical psychiatric pharmacist, Cambridge Health Alliance
Daniel Carlat, MD
Associate clinical professor, Tufts University School of Medicine
Dr. Goren and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
In this article we’ll survey those drug interactions that are most likely to become troublesome in day to day psychiatric practice.
Making the decision to put a child on a psychiatric medication is hard enough. The process of discussing this possibility with parents can be even more challenging.
In surveys, it’s clear that most psychiatrists practice as unimaginatively as I typically do, meaning that their drug of first choice for most depressed patients is an SSRI (Petersen T, et al., Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:177-187).
How high can we safely dose common psychotropics? Given the poor performance of medication combinations in recent studies, it’s time for a close look at the safety and efficacy of raising doses, sometimes known as “dose optimization.”